Inventor · disambiguated record
Pierre-Louis Tharaux
Also filed as: THARAUX PIERRE-LOUIS
6 granted patents·3 pending applications·6 citations·filing 2006–2020
72Inventor score
Files withTHARAUX PIERRE-LOUIS4INST NAT SANTE RECH MED3BLANC BRUDE OLIVIER1INSERM (INSTITUT NAT DE LA SANTÉ ET DE LA RECH MÉDICALE1
Top patents by PatentIndex Score
9 records- 0172US10034868B2Methods for the prevention and the treatment of rapidly progressive glomerulonephritisINST NAT SANTE RECH MED·Filed 2014·Granted Jul 31, 2018·3 cites·5 claims
- 0267US8198266B2Use of an EGFR antagonist for the treatment of glomerolonephritisTHARAUX PIERRE LOUIS·Filed 2006·Granted Jun 12, 2012·2 cites·2 claims
- 0357US9771584B2Methods for the prevention and the treatment of extracapillary glomerulonephritisINSERM (INSTITUT NAT DE LA SANTÉ ET DE LA RECH MÉDICALE)·Filed 2015·Granted Sep 26, 2017·1 cites·6 claims
- 0454US8586822B2Methods for producing a non human model for aortic aneurysmTHARAUX PIERRE LOUIS·Filed 2008·Granted Nov 19, 2013·0 cites·10 claims
- 0546US2023016187A1Trem-1 inhibitors for the treatment of vaso-occlusions and tissue injuries in patients suffering from sickle cell diseaseINST NAT SANTE RECH MED·Filed 2020·Application pending·0 cites
- 0644US10344279B2Methods for the prevention and the treatment of extracapillary glomerulonephritisINST NAT SANTE RECH MED·Filed 2017·Granted Jul 9, 2019·0 cites·7 claims
- 0738US10139420B2Methods for treating vaso-occlusive crisis using non-modified annexin VBLANC BRUDE OLIVIER·Filed 2012·Granted Nov 27, 2018·0 cites·4 claims
- 0835US2013236480A1Transglutaminase 2 inhibitors for use in the prevention or treatment of rapidly progressive glomerulonephritisTHARAUX PIERRE-LOUIS·Filed 2011·Application pending·0 cites
- 0934US2012283190A1Endothelin inhibitors for the treatment of rapidly progressive glomerulonephritisTHARAUX PIERRE-LOUIS·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Pierre-Louis Tharaux files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →